Table of Contents
PPT Slide
Note on Forward-Looking Statements
Why Biopure is a Good Investment
How Our Products Work
South Africa: Positive Clinical Experience
Agenda
Transitioning From R&D to Commercialization
Transition Objectives
Building Momentum
Our Strengths
1. Patented, Proprietary Manufacturing Process
2. Only Approved Products in Field
3. Hemopure: Addressing Worldwide Need
4. Important Advantages vs. RBCs
5. Demonstrated Effectiveness
6. Impressive Track Record
Market Opportunity
Three U.S. Target Markets
U.S. Orthopedic Surgery Market
Biopure In a Class of Its Own
Business Strategy
Four Point Strategy
Grow Near Term Revenues
Develop US Launch Plan
Pursue Multiple Applications/Territories
Strengthen Cash Position
Strengthen Cash Position
Milestones 2002 / 2003
Why Biopure is a Good Investment
PPT Slide
|